Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by David, R. M.
Right arrow Articles by Guest, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by David, R. M.
Right arrow Articles by Guest, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 55, 433-443 (2000)
Copyright © 2000 by the Society of Toxicology

Chronic Toxicity of Di(2-ethylhexyl)phthalate in Rats

Raymond M. David*,1, Michael R. Moore{dagger}, Dean C. Finney{ddagger} and Derek Guest*

* Health and Environment Laboratories, Eastman Kodak Company, Rochester, New York 14652–6272; {dagger} Covance Inc., Vienna, Virginia, and {ddagger} Eastman Chemical Company, Kingsport, Tennessee

Fischer 344 rats were treated with 0, 100, 500, 2500, or 12,500 ppm di(2-ethylhexyl)phthalate (DEHP) in the diet for up to 104 weeks. Blood and urine were analyzed at weeks 26, 52, 78, and 104 from 10 animals per sex per group. Survival was slightly but not statistically reduced for rats receiving 12,500 ppm DEHP. Body weights and food consumption were significantly reduced for rats receiving the highest dose level of DEHP and occasionally for the male 2500-ppm group. BUN and albumin were significantly higher and globulin lower at nearly every sampling interval for the 12,500-ppm group compared with the controls. There was an increase in the mean activities of AST and ALT at 104 weeks, but no statistically significant differences were seen. Erythrocyte count, hemoglobin, and hematocrit values for the 12,500-ppm group were significantly lower than controls at nearly every sampling interval. No other differences in hematology were seen. No toxicologically significant changes were observed in urinalysis. At termination, relative lung weights for the 2500- and 12,500-ppm male groups of rats were significantly higher than for the controls. Absolute and relative liver and kidney weights for the 2500- and 12,500-ppm male rats, and liver weights for 12,500-ppm female rats were higher compared with the controls. Absolute and relative testes weights for the 12,500-ppm male rats were lower compared with the controls. All organs were examined for histopathology. The incidence of hepatocellular lesions has been reported separately and correlated with the induction of peroxisomal enzyme activity (David et al., 1999). A dose level of 500 ppm was the NOEL for peroxisome proliferation. Bilateral aspermatogenesis in the testes, castration cells in the pituitary gland, spongiosis hepatis, and pancreatic acinar cell adenoma were observed for 12,500-ppm male rats. Aspermatogenesis and spongiosis hepatis were observed for 2500-ppm male rats, and aspermatogenesis was seen at 500 ppm. DEHP exposure exacerbated age-, species- or strain-related lesions such as mineralization of the renal papilla and chronic progressive nephropathy in male rats. Kupffer cell pigmentation and renal tubule pigmentation were seen in male and female 12,500-ppm rats. The increased incidence of spongiosis hepatis correlated with increased palmitoyl CoA oxidase activity, but the incidence of pancreatic acinar cell adenoma was increased only at the highest dose level of 12,500 ppm. These lesions, although typical of those seen with other peroxisome proliferators, may respond differently depending on the potency of the peroxisome proliferator. A dose level of 500 ppm (28.9–36.1 mg/kg/day) was considered to be theNOAEL.

Key Words: DEHP; di(2-ethylhexyl) phthalate; chronic toxicity; testes; pancreas; kidney.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
PediatricsHome page
D. Danschutter, F. Braet, E. Van Gyseghem, S. Hachimi-Idrissi, B. Van Bruwaene, P. Moloney-Harmon, and L. Huyghens
Di-(2-ethylhexyl)phthalate and Deep Venous Thrombosis in Children: A Clinical and Experimental Analysis
Pediatrics, March 1, 2007; 119(3): e742 - e753.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
P R Dalsenter, G M Santana, S W Grande, A J. Andrade, and S L Araujo
Phthalate affect the reproductive function and sexual behavior of male Wistar rats
Human and Experimental Toxicology, June 1, 2006; 25(6): 297 - 303.
[Abstract] [PDF]


Home page
Toxicol SciHome page
T. Fukuwatari, S. Ohsaki, S.-i. Fukuoka, R. Sasaki, and K. Shibata
Phthalate Esters Enhance Quinolinate Production by Inhibiting {alpha}-Amino-{beta}-Carboxymuconate-{varepsilon}-Semialdehyde Decarboxylase (ACMSD), a Key Enzyme of the Tryptophan Pathway
Toxicol. Sci., October 1, 2004; 81(2): 302 - 308.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
E. Karbe and R. L. Kerlin
Review Article: Cystic Degeneration/Spongiosis Hepatis in Rats
Toxicol Pathol, February 1, 2002; 30(2): 216 - 227.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
R. M. David, M. R. Moore, D. C. Finney, and D. Guest
Reversibility of the Chronic Effects of Di(2-ethylhexyl)phthalate
Toxicol Pathol, June 1, 2001; 29(4): 430 - 439.
[Abstract] [PDF]


Home page
Toxicol SciHome page
R. M. David, M. R. Moore, D. C. Finney, and D. Guest
Chronic Toxicity of Di(2-ethylhexyl)phthalate in Mice
Toxicol. Sci., December 1, 2000; 58(2): 377 - 385.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.